Here are five things to know:
1. This is the first time a patient-specific spinal cage won FDA approval. Medicrea designed the 3D printed titanium devices using its IB3D predictive analytics model.
2. By using its UNiD IB3D, Medicrea eliminated the implant-selection stage. This helps reduce operating time while also providing the patient with an adaptable implant.
3. The cages are designed through X-rays and MRIs prior to surgery. Since first developing patient-specific implants, Medicrea has completed more than 2,400 surgeries.
4. Medicrea’s cages build off its current patient-specific rods. The UNiD Rod earned FDA clearance in November 2014. It was the first patient-specific spinal implant to receive FDA approval.
5. Medicrea has also expanded its UNiD Adaptive Spine Intelligence platform with the new cages into its present UNiD Hub, an outcome-centered database used for surgical planning.
More articles on devices and implants:
Looking to enter the spine market? See the Xoran, Fiagon partnership
Global spine surgery products market to exceed $3.15B by 2022: 3 observations
Medtronic, Aurora Spine & more: 4 device company notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
